Systematic Intervention to Improve Sexual Dysfunction
Launched by CENTER EUGENE MARQUIS · Sep 2, 2024
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how different types of care can help improve sexual health for women who have localized breast cancer. The study compares two approaches: one where women receive ongoing, organized support from a team of specialists focused on sexual health (called oncosexological care), and another where help is available only when women ask for it. The goal is to see which method works better in enhancing sexual well-being.
To participate, women must be 18 years or older and have localized breast cancer, meaning the cancer hasn't spread far. They should be starting treatment that includes surgery and possibly other therapies like chemotherapy or hormone therapy. Unfortunately, women who have had other types of cancer recently, are pregnant or breastfeeding, or have certain legal restrictions cannot join. If eligible, participants can expect to receive support and information about their sexual health throughout their treatment. This study aims to ensure that women dealing with breast cancer have the resources they need for a better quality of life.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women ≥ 18 years (menopausal or not),
- • Localized breast cancer with or without lymph node involvement,
- • Initial treatment starting with surgical resection, whatever the associated therapy (chemotherapy, radiotherapy, hormone therapy, monoclonal antibody, conjugated drug antibody, targeted therapy such as cyclin and anti-PARP inhibitors, etc.),
- • Patient affiliated or benefiting from the social security system,
- • Patient informed and informed consent signed.
- Exclusion Criteria:
- • History of cancer (except squamous cell carcinoma or basal cell carcinoma) in the last five years,
- • Pregnant or breast-feeding women,
- • Patients deprived of their liberty, under guardianship or curatorship and all other administrative safeguards,
- • Patients unable to comply with the study schedule for social, medical or psychological reasons.
About Center Eugene Marquis
Center Eugene Marquis is a leading clinical research organization dedicated to advancing oncology through innovative research and patient-centered care. Located in Rennes, France, the center specializes in conducting high-quality clinical trials aimed at evaluating new therapies and improving treatment outcomes for cancer patients. With a multidisciplinary team of experienced professionals and state-of-the-art facilities, Center Eugene Marquis collaborates with academic institutions, pharmaceutical companies, and other stakeholders to foster groundbreaking discoveries and contribute to the global fight against cancer.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rennes, Bretagne, France
Patients applied
Trial Officials
Claudia Lefeuvre-Plesse, MD
Principal Investigator
Centre de Lutte Contre Le cancer Eugène Marquis
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported